Stock Screener App

Gratuito -

Installare

1.78

14.84% 0.23

after-market

Dopo l'orario di chiusura: 1.71 -0.07 -3.93%

Aldeyra Therapeutics Inc (ALDX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie

Portnoy Law Firm Announces Class Action on Behalf of Aldeyra Therapeutics, Inc. Investors - GlobeNewswire

ALDX Shareholder Alert: Aldeyra Therapeutics, Inc. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - PR Newswire

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

ALDX FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Aldeyra Therapeutics, Inc. ... - Caledonian Record

ALDX FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 29 Deadline in Securities Class Action First Filed by the Firm – ALDX - GlobeNewswire Inc.

ALDX Deadline: ALDX Investors with Losses in Excess of $100K Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - PR Newswire

Press releases provided by CNW - Techaeris

Aldeyra Therapeutics, Inc.Common Stock (NQ: ALDX - The Chronicle-Journal

ALDX Stockholders Have Opportunity to Lead Aldeyra Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

ALDX Shareholders Have Opportunity to Lead Aldeyra Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

ALDX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - Sahm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming DeadlinesALDX - PR Newswire

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsu - GuruFocus

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Submitted Incomplete Disclosures: SueWallSt - PR Newswire

Is Aldeyra Therapeutics on the Brink of a Breakthrough with Reproxalap - Kavout

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Robbins LLP Reminds ALDX Investors of the Pending Class - GlobeNewswire

Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

ALDX DEADLINE: The Gross Law Firm Reminds Aldeyra Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Aldeyra’s Experimental Drug Shows Promising Results In Mid-Stage Alcohol Hepatitis Trial - MSN

ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. - GuruFocus

ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmALDX - Charleston Gazette-Mail

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Babcock & Wilcox Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud - GlobeNewswire

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra - GlobeNewswire

ALDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

ALDX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Perceptive (ALDX) amendment shows 0% ownership; Joseph Edelman signs - Stock Titan

Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against Aldeyra Therapeutics, Inc. – ALDX - ACCESS Newswire

ALDX Deadline Alert: The Gross Law Firm Reminds Aldeyra Therapeutics, Inc. (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - The Daily Tribune News

ALDX SEC FilingsAldeyra Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

ALDX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - ChartMill

ALDX Stockholders Have Opportunity to Lead Aldeyra Therapeutics - The National Law Review

ALDX DEADLINE NOTICE: Aldeyra Therapeutics, Inc. Investors Encouraged to Contact Kirby McInerney LLP By May 29, 2026 - ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX - ChartMill

About Us - FinancialContent

ALDX DEADLINE: The Gross Law Firm Reminds Aldeyra Therapeutics, - GuruFocus

ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra - GlobeNewswire

ALDX SHAREHOLDER RIGHTS ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 - TMX Newsfile

symbol__ Stock Quote Price and Forecast - CNN

MSN Money - MSN

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmALDX - TMX Newsfile

H.C. Wainwright Maintains Aldeyra Therapeutics(ALDX.US) With Hold Rating, Maintains Target Price $2 - Moomoo

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - ChartMill

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to ... - Black Hills Pioneer

ROIV

$29.66

0.98%

BNTX

$92.25

0.12%

INSM

$108.87

2.48%

RPRX

$53.86

1.17%

ONC

$302.44

2.52%

RVMD

$154.89

2.20%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters